Components for a respiratory treatment apparatus that is capable of providing a humidified respiratory treatment permit a reduction in condensation in a patient interface and/or its gas delivery tubing. In some embodiments, a rainout valve that may be an integrated component of a humidifier output aperture, or coupled thereto, may reduce condensation with a vapor barrier operable to selectively block and permit humidified gas transfer from the humidifier. For example, the barrier may be operable to open in response to a flow of pressurized breathable gas that may be generated by a flow generator of the respiratory treatment apparatus. In the absence of such a generation of pressurized flow, the barrier may prevent a transfer of the humidified gas such as into a conduit for a patient interface by retracting to a closed position. Example vapor barriers may include a resilient membrane, cover, bellows, flap, shutter or other suitable valve.

Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.

The present invention provides a gas inhalation device with a constant concentration of gas entering the respiratory tract and without respiratory resistance, including: a mask, a gas source and a gas mixer, wherein the mask is a container that is capable of holding 50-1000 ml of gas, a proximal end of the mask is a soft cushion for fitting the face and surrounded by a catheter, the catheter is provided with a plurality of small orifices communicating with an inner cavity of the mask, one end of the catheter is connected to one end of an adapter tube, the other end of the adapter tube is connected to a gas delivery pipe, the gas delivery pipe is a catheter connecting the adapter tube and the gas source or the gas mixer; a distal end of the mask is provided with a huge orifice or a plurality of large orifices to ensure unobstructed gas in and out, with almost no airflow resistance, and an internal pressure of the mask cavity is always zero; one or two headband interfaces are provided on both sides of the mask's outer layer for connecting a headband fixing the mask to ensure that the mask is stably fixed on the face.

The present invention provides a gas inhalation device with a constant concentration of gas entering the respiratory tract and without respiratory resistance, including: a mask, a gas source and a gas mixer, wherein the mask is a container that is capable of holding 50-1000 ml of gas, a proximal end of the mask is a soft cushion for fitting the face and surrounded by a catheter, the catheter is provided with a plurality of small orifices communicating with an inner cavity of the mask, one end of the catheter is connected to one end of an adapter tube, the other end of the adapter tube is connected to a gas delivery pipe, the gas delivery pipe is a catheter connecting the adapter tube and the gas source or the gas mixer; a distal end of the mask is provided with a huge orifice or a plurality of large orifices to ensure unobstructed gas in and out, with almost no airflow resistance, and an internal pressure of the mask cavity is always zero; one or two headband interfaces are provided on both sides of the mask's outer layer for connecting a headband fixing the mask to ensure that the mask is stably fixed on the face.

Methods and devices for delivering one or more substances within at least one body cavity are provided. The device includes at least one nosepiece including at least one capsule having a volume V.sub.sub of the substances; at least one base in communication with the nosepiece, the base including at least one chamber configured to confine pressurized fluid at volume V.sub.PF and pressure P.sub.PF; and at least one hollow puncturing member. The hollow puncturing member includes at least one end in fluid communication with the nosepiece and a second end in fluid communication with the base. The first and second ends are fluidly interconnected by a hollow tube. The fluid inlet port of the capsule is configured in terms of size and shape to interface in a sealable manner with the one end of the at least one puncturing member.

A method for performing cold atmospheric plasma treatment of respiratory infections or lung cancer having a source of a carrier gas, a cold atmospheric plasma generator connected to the source of carrier gas, a source of compressed air, a humidifier connected to the source of compressed air, a source of oxygen, a ventilator having inputs connected to an output of the humidifier and the source of oxygen, a mixer having an interior chamber formed from a dielectric, an active electrode inside the interior chamber, and an outer electrode connected to ground, wherein the mixer has a fluid input port connected to a gas output of the cold atmospheric plasma generator and an output of the ventilator, and a delivery member connected to an output of the mixer for delivering combined humidified air and cold atmospheric plasma to a respiratory system of a patient.

A system for performing cold atmospheric plasma treatment of respiratory infections or lung cancer having a source of a carrier gas, a cold atmospheric plasma generator connected to the source of carrier gas, a source of compressed air, a humidifier connected to the source of compressed air, a source of oxygen, a ventilator having inputs connected to an output of the humidifier and the source of oxygen, a mixer having an interior chamber formed from a dielectric, an active electrode inside the interior chamber, and an outer electrode connected to ground, wherein the mixer has a fluid input port connected to a gas output of the cold atmospheric plasma generator and an output of the ventilator, and a delivery member connected to an output of the mixer for delivering combined humidified air and cold atmospheric plasma to a respiratory system of a patient.

Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.

This invention relates to a method or system for providing an indication or establishment of airway patency of a patient comprising monitoring of at least one targeted gas (e.g. CO2, N2 or may be other gases capable of being detected, monitored, and measured) that is being expired or being expelled from an airway of a patient (e.g. an apnoeic or non-spontaneously breathing patient), and based on measurements of the at least one targeted gas for a period of time, providing an indicator as to an output of the measurements of the at least one targeted gas for the period of time, or a determination as to airway patency, or a determination as to a location of a blockage or obstruction in the airway, or combinations of these.

A nebulizer is used to prevent infection by coronavirus by nebulizing a combination of hydrogenated water and ethyl alcohol, one or both of which have a counterclockwise spin polarization, into a vapor-aerosol mixture for inhalation by a patient. A storage container of helium adjacent to or in communication with an inside of the nebulizer increases partial pressure of the vapor-aerosol mixture during usage. The nebulizer may also nebulize into the vapor-aerosol mixture, one of the following third ingredient (a) hydrogen peroxide, (b) a low dosage of hydroxychloroquine or chloroquine (c) a very low dosage of a mixture of sodium chlorite with food-grade citric acid solution, (d) antibiotics. The third ingredient may vary to thwart development of resistance. A nebulized vapor-aerosol mixture produced by nebulizing a combination of ingredients is presented. A method of delivering a combination of ingredients directly to the lungs of a subject, at times bolstered by helium.